Ascendis Pharma A/S Nonderivative Financial Liabilities Undiscounted Cash Flows
Ascendis Pharma A/S (ASND) had Nonderivative Financial Liabilities Undiscounted Cash Flows of EUR 963.49 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows · last filed 2026-02-11
- 2025-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 963.49M EUR.
- 2024-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 953.32M EUR.
- 2023-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 738.83M EUR.
- 2022-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 609.41M EUR.
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2025-12-31 | 963.49M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 953.32M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 738.83M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 609.41M EUR 20-F · filed 2024-02-07 |
| 2021-12-31 | 164.38M EUR 20-F · filed 2023-02-16 |